Harold Varmus has worked at the US National Institutes of Health three times: right out of medical school, as its director, and as the director of its cancer institutes, he tells The Journal of the American Medical Association.

"I learned the thrills of being at the [scientific] frontier and asking questions," he adds. "I gave up clinical medicine, went into basic research in virology and the origins of cancer, and developed a deep affection for the NIH."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.